Product Surveillance Registry (PSR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Medtronic
Information provided by (Responsible Party):
Medtronic Identifier:
First received: January 30, 2012
Last updated: November 4, 2013
Last verified: November 2013

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Cardiac Rhythm Disorders
Urological and Digestive Disorders
Neurological Disorders

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Medtronic Product Surveillance Registry

Resource links provided by NLM:

Further study details as provided by Medtronic:

Estimated Enrollment: 3300
Study Start Date: January 2012

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects implanted with Medtronic qualifying therapy product.


Inclusion Criteria:

  • Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • Patient has or is intended to receive or be treated with an eligible Medtronic product
  • Patient within 30 days of therapy initiation or meets criteria for retrospective enrollment

Exclusion Criteria:

  • Patient who is, or will be, inaccessible for follow-up
  • Patient with exclusion criteria required by local law
  • Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01524276

Contact: Medtronic Product Surveillance Registry

  Show 101 Study Locations
Sponsors and Collaborators
  More Information

No publications provided

Responsible Party: Medtronic Identifier: NCT01524276     History of Changes
Other Study ID Numbers: PSR
Study First Received: January 30, 2012
Last Updated: November 4, 2013
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board
Canada: Ethics Review Committee
France: Conseil National de l'Ordre des Médecins
Germany: Federal Institute for Drugs and Medical Devices
Serbia: Agency for Drugs and Medicinal Devices
Serbia: Ethics Committee
Austria: Ethikkommission
Denmark: Ethics Committee
Switzerland: Swissmedic
Switzerland: Ethikkommission
Sweden: Regional Ethical Review Board
Italy: Ethics Committee
Australia: Human Research Ethics Committee
Netherlands: Independent Ethics Committee
United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Nervous System Diseases
Digestive System Diseases
Arrhythmias, Cardiac
Pathologic Processes
Heart Diseases
Cardiovascular Diseases processed this record on September 16, 2014